{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:37:19Z","timestamp":1790818639745,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,6,19]],"date-time":"2010-06-19T00:00:00Z","timestamp":1276905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11908-010-0119-y","type":"journal-article","created":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T06:09:05Z","timestamp":1276841345000},"page":"392-400","source":"Crossref","is-referenced-by-count":63,"title":["Staphylococcal Toxic Shock Syndrome: Mechanisms and Management"],"prefix":"10.1007","volume":"12","author":[{"given":"Jonathan A.","family":"Silversides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Lappin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,19]]},"reference":[{"key":"119_CR1","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(78)92274-2","volume":"2","author":"J Todd","year":"1978","unstructured":"Todd J, Fishaut M, Kapral F, et al.: Toxic-shock syndrome associated with phage-group-1 staphylococci. Lancet 1978, 2:1116\u20131118.","journal-title":"Lancet"},{"key":"119_CR2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3201\/eid0506.990611","volume":"5","author":"RA Hajjeh","year":"1999","unstructured":"Hajjeh RA, Reingold A, Weil A, et al.: Toxic shock syndrome in the United States: surveillance update, 1979\u20131996. Emerg Infect Dis 1999, 5:807\u2013810.","journal-title":"Emerg Infect Dis"},{"key":"119_CR3","first-page":"398","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC): Notifiable diseases and mortality tables. MMWR 2010, 59:398\u2013411.","journal-title":"MMWR"},{"key":"119_CR4","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1128\/JCM.42.6.2875-2876.2004","volume":"42","author":"PM Schlievert","year":"2004","unstructured":"Schlievert PM, Tripp TJ, Peterson ML: Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St Paul, Minnesota, during the 2000\u20132003 surveillance period. J Clin Microbiol 2004, 42:2875\u20132876.","journal-title":"J Clin Microbiol"},{"key":"119_CR5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","volume":"5","author":"HFL Wertheim","year":"2005","unstructured":"Wertheim HFL, Melles DC, Vos MC, et al.: The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005, 5:751\u2013762.","journal-title":"Lancet Infect Dis"},{"key":"119_CR6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.7326\/0003-4819-96-6-944","volume":"96","author":"ME Guinan","year":"1982","unstructured":"Guinan ME, Dan BB, Guidotti RJ, et al.: Vaginal colonization with Staphylococcus aureus in healthy women. Ann Intern Med 1982, 96:944\u2013947.","journal-title":"Ann Intern Med"},{"key":"119_CR7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10096-009-0761-1","volume":"28","author":"S Schlebusch","year":"2009","unstructured":"Schlebusch S, Schooneveldt JM, Huygens F, et al.: Prevalence of Staphylococcus aureus strains in an Australian cohort, 1989\u20132003: evidence for the low prevalence of the toxic shock toxin and Panton\u2013Valentine leukocidin genes. Eur J Clin Microbiol Infect Dis 2009, 28:1183\u20131189.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"119_CR8","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1128\/JCM.43.9.4628-4634.2005","volume":"43","author":"J Parsonnet","year":"2005","unstructured":"Parsonnet J, Hansmann MA, Delaney ML, et al.: Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol 2005, 43:4628\u20134634.","journal-title":"J Clin Microbiol"},{"key":"119_CR9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/JCM.44.3.847-853.2006","volume":"44","author":"G Durand","year":"2006","unstructured":"Durand G, Bes, M, Meugnier H, et al.: Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol 2006, 44:847\u2013853.","journal-title":"J Clin Microbiol"},{"key":"119_CR10","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1128\/JCM.00228-08","volume":"46","author":"J Parsonnet","year":"2008","unstructured":"Parsonnet J, Goering RV, Hansmann MA, et al.: Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women. J Clin Microbiol 2008, 46:2731\u20132738.","journal-title":"J Clin Microbiol"},{"key":"119_CR11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1469-0691.2008.02118.x","volume":"15","author":"RR Souza","year":"2009","unstructured":"Souza RR, Coelho LR, Botelho AMN, et al.: Biofilm formation and prevalence of lukF-pv, seb, sec and tst genes among hospital- and community-acquired isolates of some international methicillin-resistant Staphylococcus aureus lineages. Clin Microbiol Infect 2009, 15:203\u2013207.","journal-title":"Clin Microbiol Infect"},{"key":"119_CR12","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1128\/JCM.02264-08","volume":"47","author":"B Limbago","year":"2009","unstructured":"Limbago B, Fosheim GE, Schoonover V, et al.: Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol 2009, 47:1344\u20131351.","journal-title":"J Clin Microbiol"},{"key":"119_CR13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1099\/jmm.0.2008\/002790-0","volume":"57","author":"D Hu","year":"2008","unstructured":"Hu D, Omoe K, Inoue F, et al.: Comparative prevalence of superantigenic toxin genes in meticillin-resistant and methicillin susceptible Staphylococcus aureus isolates. J Med Microbiol 2008, 57:1106\u20131112.","journal-title":"J Med Microbiol"},{"key":"119_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-065X.2008.00681.x","volume":"225","author":"JD Fraser","year":"2008","unstructured":"\u2022\u2022 Fraser JD, Proft T: The bacterial superantigen and superantigen-like proteins. Immunol Rev 2008, 225:226\u2013243. A thorough and useful overview of the current knowledge of superantigen structure, activity, and the pathophysiology of superantigen-mediated disease.","journal-title":"Immunol Rev"},{"key":"119_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(89)90980-X","volume":"56","author":"J White","year":"1989","unstructured":"White J, Herman A, Pullen AM, et al.: The V-beta specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989, 56:27\u201335.","journal-title":"Cell"},{"key":"119_CR16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(02)00222-0","volume":"2","author":"M Llewelyn","year":"2002","unstructured":"Llewelyn M, Cohen J: Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2002, 2:156\u2013162.","journal-title":"Lancet Infect Dis"},{"key":"119_CR17","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/IAI.01388-08","volume":"77","author":"D Thomas","year":"2009","unstructured":"\u2022 Thomas D, Dauwalder O, Brun V, et al.: Staphylococcus aureus superantigens elicit redundant and extensive human V\u03b2 patterns. Infect Immun 2009, 77:2043\u20132050. This study goes into considerable depth to elucidate specific superantigen V\u03b2 signatures, although the authors found significant variation and overlap in V\u03b2 T-cell responses to staphylococcal superantigens.","journal-title":"Infect Immun"},{"key":"119_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","volume":"55","author":"JK McCormick","year":"2001","unstructured":"McCormick JK, Yarwood JM, Schlievert PM: Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 2001, 55:77\u2013104.","journal-title":"Annu Rev Microbiol"},{"key":"119_CR19","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.4049\/jimmunol.175.10.6870","volume":"175","author":"L Faulkner","year":"2005","unstructured":"Faulkner L, Cooper A, Fantino C, et al.: The mechanism of superantigen mediated toxic shock: not a simple Th1 cytokine storm. J Immunol 2005, 175: 6870\u20136877.","journal-title":"J Immunol"},{"key":"119_CR20","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.4049\/jimmunol.150.12.5604","volume":"150","author":"NS Trede","year":"1993","unstructured":"Trede NS, Castigli E, Geha RS, et al.: Microbial superantigens induce NF-kappa B in the human monocytic cell line THP-1. J Immunol 1993, 150:5604\u20135613.","journal-title":"J Immunol"},{"key":"119_CR21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/CCM.0b013e31816a0a78","volume":"36","author":"P Hopkins","year":"2008","unstructured":"Hopkins P, Pridmore AC, Ellmerich S, et al.: Increased surface toll-like receptor 2 expression in superantigen shock. Crit Care Medicine 2008, 36:1267\u20131276.","journal-title":"Crit Care Medicine"},{"key":"119_CR22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1183021","volume":"327","author":"A Iwasaki","year":"2010","unstructured":"\u2022 Iwasaki A, Medzhitov R: Regulation of adaptive immunity by the innate immune system. Science 2010, 327: 291\u2013295. This article provides a very good review of the process of pathogen recognition by the host, including secreted, transmembrane, and cytosolic receptors for pathogen-associated molecular patterns.","journal-title":"Science"},{"key":"119_CR23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nm.1965","volume":"15","author":"TA Chau","year":"2009","unstructured":"\u2022 Chau TA, McCully ML, Brintnell W, et al.: Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med 2009, 15:641\u2013649. This study offers a potential explanation for the low frequency of toxic shock syndrome despite widespread colonization and infection, based on the ability of TLR2 activation to modulate inflammation.","journal-title":"Nat Med"},{"key":"119_CR24","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Mele T, Madrenas J: TLR2 signalling: at the crossroads of commensalism, invasive infections and toxic shock syndrome by Staphylococcus aureus. Int J Biochem Cell Biol 2010 (Epub ahead of print). An excellent review highlighting the potential for TLR2-mediated immunomodulation and the impact of a dual pro- and anti-inflammatory outcome from staphylococcal exposure on our approach to TSS.","DOI":"10.1016\/j.biocel.2010.03.021"},{"key":"119_CR25","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.4049\/jimmunol.0803283","volume":"182","author":"A Brosnahan","year":"2009","unstructured":"Brosnahan A, Mantz MJ, Squier CA, et al.: Cytolysins augment the superantigen penetration of stratified mucosa. J Immunol 2009, 182:2364\u20132373.","journal-title":"J Immunol"},{"key":"119_CR26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/infdis\/151.5.883","volume":"151","author":"SJ Stolz","year":"1985","unstructured":"Stolz SJ, Davis JP, Vergeront JM, et al.: Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin. J Infect Dis 1985, 151:883\u2013889.","journal-title":"J Infect Dis"},{"key":"119_CR27","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.4049\/jimmunol.172.3.1719","volume":"172","author":"M Llewelyn","year":"2004","unstructured":"Llewelyn M, Sriskandan S, Peakman M, et al.: HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol 2004, 172:1719\u20131726.","journal-title":"J Immunol"},{"key":"119_CR28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/00325481.1993.11945747","volume":"94","author":"LJ Strausburgh","year":"1993","unstructured":"Strausburgh LJ: Toxic shock syndrome: are you recognizing its changing presentations? Postgrad Med 1993, 94:107\u2013108.","journal-title":"Postgrad Med"},{"key":"119_CR29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2500\/ajra.2009.23.3313","volume":"23","author":"LM El-Fiky","year":"2009","unstructured":"El-Fiky LM, Khamis N, Mostafa Bel D, Adly AM: Staphylococcal infection and toxin production in chronic rhinosinusitis. Am J Rhinol Allergy 2009, 23:264\u2013267.","journal-title":"Am J Rhinol Allergy"},{"key":"119_CR30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archoto.2009.55","volume":"135","author":"KH Chan","year":"2009","unstructured":"Chan KH, Kraai TL, Richter GT, et al.: Toxic shock syndrome and rhinosinusitis in children. Arch Otolaryngol Head Neck Surg 2009, 135:538\u2013542.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"119_CR31","first-page":"1","volume":"39","author":"M Wharton","year":"1990","unstructured":"Wharton M, Chorba Tl, Vogt RL, et al.: Case definitions for public health surveillance. MMWR Recomm Rep 1990, 39:1\u201343.","journal-title":"MMWR Recomm Rep"},{"key":"119_CR32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1189\/jlb.0108074","volume":"85","author":"M Waclavicek","year":"2009","unstructured":"Waclavicek M, Stich N, Rappan I, et al.: Analysis of the early response to TSST-1 reveals Vbeta-unrestricted extravasation, compartmentalization of the response, and unresponsiveness but not anergy to TSST-1. J Leukoc Biol 2009, 85:44\u201354.","journal-title":"J Leukoc Biol"},{"key":"119_CR33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/JCM.01411-09","volume":"48","author":"K Granger","year":"2010","unstructured":"Granger K, Rundell MS, Pingle MR, et al.: Multiplex PCR-ligation detection reaction assay for simultaneous detection of drug resistance and toxin genes from Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium. J Clin Microbiol 2010, 48:277\u2013280.","journal-title":"J Clin Microbiol"},{"key":"119_CR34","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1472-765X.2003.01330.x","volume":"36","author":"V Javid Khojasteh","year":"2003","unstructured":"Javid Khojasteh V, Rogan MT, Edwards-Jones V, et al.: Detection of antibodies to Staphylococcus aureus toxic shock syndrome toxin-1 using a competitive agglutination inhibition assay. Lett Appl Microbiol 2003, 36:372\u2013376.","journal-title":"Lett Appl Microbiol"},{"key":"119_CR35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1469-0691.2008.01975.x","volume":"14","author":"T Ferry","year":"2008","unstructured":"Ferry T, Thomas D, Perpoint T, et al.: Analysis of superantigenic toxin Vb T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock. Clin Microbiol Infect 2008, 14: 546\u2013554.","journal-title":"Clin Microbiol Infect"},{"key":"119_CR36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/INF.0b013e31815c93a3","volume":"27","author":"T Ferry","year":"2008","unstructured":"Ferry T, Thomas D, Bouchut J, et al.: Early diagnosis of staphylococcal toxic shock syndrome by detection of the tsst-1 v beta signature in peripheral blood of a 12-year-old boy. Ped Infect Dis J 2008, 27:274\u2013277.","journal-title":"Ped Infect Dis J"},{"key":"119_CR37","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1099\/jmm.0.010116-0","volume":"58","author":"H Gbaguidi-Haore","year":"2009","unstructured":"\u2022 Gbaguidi-Haore H,Thouverez M, Couetdic G, et al.: Usefulness of antimicrobial resistance pattern for detecting PVL- or TSST-1-producing methicillin resistant Staphylococcus aureus in a French university hospital. J Med Microbiol 2009, 58:1337\u20131342. This useful paper demonstrates the potential to determine the likelihood of toxin production by MRSA based on local antimicrobial resistance pattern, once a reference study on toxin production by local isolates has been done.","journal-title":"J Med Microbiol"},{"key":"119_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","volume":"34","author":"RP Dellinger","year":"2008","unstructured":"\u2022\u2022 Dellinger RP, Levy MM, Carlet JM, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Int Care Med 2008, 34:17\u201360. This article provides an evidence-based, worldwide, consensus statement on current therapy for sepsis and septic shock, emphasizing the importance of early intervention and attention to detail.","journal-title":"Int Care Med"},{"key":"119_CR39","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"E Rivers","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S, et al.: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368\u20131377.","journal-title":"N Engl J Med"},{"key":"119_CR40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.2010.158","volume":"303","author":"AE Jones","year":"2010","unstructured":"\u2022 Jones AE, Shapiro NI, Trzeciak S, et al.: Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010, 303:739\u2013746. This article describes a randomized controlled trial of two resuscitation endpoints, demonstrating noninferiority of the more readily measured lactate clearance as compared to central venous oxygen saturation.","journal-title":"JAMA"},{"key":"119_CR41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D DeBacker","year":"2010","unstructured":"DeBacker D, Biston P, Devriendt J, et al.: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010, 362:779\u2013789.","journal-title":"N Engl J Med"},{"key":"119_CR42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0022-3859.57393","volume":"55","author":"V Gupta","year":"2009","unstructured":"Gupta V, Datta P, Rani H, Chander J: Inducible clindamycin resistance in Staphylococcus aureus: a study from North India. J Postgrad Med 2009, 55:176\u2013179.","journal-title":"J Postgrad Med"},{"key":"119_CR43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1155\/2008\/714846","volume":"19","author":"GG Zhanel","year":"2008","unstructured":"Zhanel GG, DeCorby M, Nichol KA, et al.: Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005\u20132006). Can J Infect Dis Med Microbiol 2008, 19:243\u2013249.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"119_CR44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/510396","volume":"195","author":"DL Stevens","year":"2007","unstructured":"Stevens DL, Ma Y, Salmi DB, et al.: Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 2007, 195:202\u2013211.","journal-title":"J Infect Dis"},{"key":"119_CR45","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/08923970902838672","volume":"31","author":"R Saliba","year":"2009","unstructured":"Saliba R, Paasch L, El Solh A: Tigecycline attenuates staphylococcal superantigen-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol Immunotoxicol 2009, 31:583\u2013588.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"119_CR46","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/jac\/dkq110","volume":"65","author":"P Baudoux","year":"2010","unstructured":"Baudoux P, Lemaire S, Denis O, et al.: Activity of quinupristin\/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes. J Antimicrob Chemother 2010, 65:1228\u20131236.","journal-title":"J Antimicrob Chemother"},{"key":"119_CR47","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1067\/mai.2001.117820","volume":"108","author":"PM Schlievert","year":"2001","unstructured":"Schlievert PM: Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J Allergy Clin Immunol 2001, 108:S107\u2013S110.","journal-title":"J Allergy Clin Immunol"},{"key":"119_CR48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","volume":"37","author":"J Darenberg","year":"2003","unstructured":"Darenberg J, Ihendyane N, Sjolin J: Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003, 37:333\u2013340.","journal-title":"Clin Infect Dis"},{"key":"119_CR49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2332\/allergolint.O-06-462","volume":"56","author":"K Kato","year":"2007","unstructured":"Kato K, Sakamoto T, Ito K: Gamma-globulin inhibits superantigen-induced lymphocyte proliferation and cytokine production. Allergol Int 2007, 56: 439\u2013444.","journal-title":"Allergol Int"},{"key":"119_CR50","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/381979","volume":"38","author":"J Darenberg","year":"2004","unstructured":"Darenberg J, S\u00f6derquist B, Normark BH, Norrby-Teglund A: Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin Infect Dis 2004, 38:836\u2013842.","journal-title":"Clin Infect Dis"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-010-0119-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-010-0119-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-010-0119-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T17:04:02Z","timestamp":1685639042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-010-0119-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,19]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["119"],"URL":"https:\/\/doi.org\/10.1007\/s11908-010-0119-y","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,19]]}}}